FDA Inspection
Omega & Delta Co., Inc.Omega & Delta Co., Inc. – FDA Inspection, Oct 23, 2023
Record Details
This FDA Inspection record concerns Omega & Delta Co., Inc., with an inspection on October 23, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 06ef66b0-2aad-4e88-b5c5-a999005485bf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1221655
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.22(a)Lack of quality control unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Omega & Delta Co., Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| May 6, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 10, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Omega & Delta Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.